Article Text

Download PDFPDF
Brimonidine (Alphagan) associated anterior uveitis
  1. Charlotte M McKnight1,
  2. Josephine C Richards1,
  3. Dru Daniels2,
  4. William H Morgan1
  1. 1Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia, Australia
  2. 2St John of God Hospital, Subiaco, Western Australia, Australia
  1. Correspondence to Dr Josephine C Richards, Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia 6000, Australia; diastella{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Brimonidine is a well-recognised cause of ocular surface disease but is less widely known to cause uveitis. We present important clinical lessons from five new cases of brimonidine-associated anterior uveitis.

Case reports

1. A 64-year-old man with primary open-angle glaucoma presented with red eyes and visual halos. He had used brimonidine 0.2%, timolol 0.5% and bimatoprost 0.03% for 13 months. There was bilateral anterior chamber inflammation with diffuse pigmented and stellate keratic precipitates. His intraocular pressure was 21 mm Hg bilaterally, rising to 26 mm Hg 3 weeks later. A trabeculectomy was planned, but cessation of brimonidine …

View Full Text


  • Correction notice This article has been corrected since it was published Online First. Spelling errors in table 1 have been corrected and the title for table 1 has been added.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement Additional data and explanatory material are available on request from the corresponding author.